Treatment with metformin glycinate reduces SARS-CoV-2 viral load: An in vitro model and randomized, double-blind, Phase IIb clinical trial

The health crisis caused by the new coronavirus SARS-CoV-2 highlights the need to identify new treatment strategies for this viral infection. During the past year, over 400 coronavirus disease (COVID-19) treatment patents have been registered; nevertheless, the presence of new virus variants has tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Ventura-López, Claudia, Cervantes-Luevano, Karla, Aguirre-Sánchez, Janet S., Flores-Caballero, Juan C., Alvarez-Delgado, Carolina, Bernaldez-Sarabia, Johanna, Sánchez-Campos, Noemí, Lugo-Sánchez, Laura A., Rodríguez-Vázquez, Ileana C., Sander-Padilla, Jose G., Romero-Antonio, Yulia, Arguedas-Núñez, María M., González-Canudas, Jorge, Licea-Navarro, Alexei F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159967/
https://www.ncbi.nlm.nih.gov/pubmed/35709650
http://dx.doi.org/10.1016/j.biopha.2022.113223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159967/
https://www.ncbi.nlm.nih.gov/pubmed/35709650
http://dx.doi.org/10.1016/j.biopha.2022.113223

Ejemplares similares